Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Financials

Summary of Key Figures

More detailed information and explanations can be found in our Interim reports and Annual Report.

(1,000 DKK)20242023202220212020
Revenue36,24330,95828,96924,25423,204
Operating profit/loss before interest and tax (EBIT)(75,452)(61,172)81,527(65,255)(63,590)
Operating profit/loss before tax(73,743)(61,207)(81,547)(63,840)(66,834)
Net Loss(68,243)(56,328)(75,923)(57,113)(61,562)